Learn More
BACKGROUND Late adverse events such as very late stent thrombosis (VLST) or late target-lesion revascularization (TLR) after first-generation sirolimus-eluting stents (SES) implantation have not been(More)
BACKGROUND Optimal duration of dual antiplatelet therapy (DAPT) after drug-eluting stent (DES) implantation has not been yet fully elucidated. METHODS AND RESULTS We assessed the influence of(More)
  • 1